Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Aleksi Šedo, Jarmila Stremenová, Petr Bušek & Jonathan S Duke-Cohan. (2008) Dipeptidyl peptidase-IV and related molecules: markers of malignancy?. Expert Opinion on Medical Diagnostics 2:6, pages 677-689.
Read now
Read now
N. Aguilera-Montilla, M. Pérez-Blas, A. P. Valeri, M. López-Santalla, C. Rodríguez-Juan, Á. Mencía, G. Castellano, M. L. Manzano, B. Casis, F. Sánchez & J. M. Martín-Villa. (2004) Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scandinavian Journal of Gastroenterology 39:12, pages 1236-1242.
Read now
Read now
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé & Ingrid De Meester. (2003) Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV. Critical Reviews in Clinical Laboratory Sciences 40:3, pages 209-294.
Read now
Read now
Articles from other publishers (60)
Erfaneh Jafari, Niloufar Soleymani, Masoud Hamidi, Azar Rahi, Akram Rezaei & Reza Azizian*. (2024) Celiac Disease: A Review from Genetic to Treatment. Iranian Biomedical Journal 28:1, pages 8-14.
Crossref
Crossref
Li Zhang, Anna Hu, Yan Wang, Yuxin Yang, Yalan Liu, Lian Xu, Lei Wang & Zeneng Cheng. (2023) Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats. Neoplasia 43, pages 100922.
Crossref
Crossref
Chunli Hu, Shengtao Liao, Lin Lv, Chuanfei Li & Zhechuan Mei. (2023) Intestinal Immune Imbalance is an Alarm in the Development of IBD. Mediators of Inflammation 2023, pages 1-17.
Crossref
Crossref
Panagiotis Theofilis, Marios Sagris, Evangelos Oikonomou, Alexios S. Antonopoulos, Gerasimos Siasos, Kostas Tsioufis & Dimitris Tousoulis. (2022) The Anti-Inflammatory Effect of Novel Antidiabetic Agents. Life 12:11, pages 1829.
Crossref
Crossref
Xiaopeng Hu, Xisheng Wang & Xingkui Xue. (2022) Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. Molecules 27:14, pages 4498.
Crossref
Crossref
An Bracke, Emilie De Hert, Michelle De bruyn, Karen Claesen, Gwendolyn Vliegen, Alexandra Vujkovic, Lida van Petersen, Fien H.R. De Winter, An Hotterbeekx, Isabel Brosius, Caroline Theunissen, Sabrina Van Ierssel, Maartje van Frankenhuijsen, Erika Vlieghe, Koen Vercauteren, Pieter Van der Veken, Dirk Hendriks, Samir Kumar-Singh & Ingrid De Meester. (2022) Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients. Clinica Chimica Acta 531, pages 4-11.
Crossref
Crossref
Jie Huang, Xinxin Liu, Yingying Wei, Xinlu Li, Shupei Gao, Lingli Dong, Xiaoquan Rao & Jixin Zhong. (2022) Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease. Frontiers in Immunology 13.
Crossref
Crossref
Giuseppe Lia, Clara Di Vito, Stefania Bruno, Marta Tapparo, Lucia Brunello, Armando Santoro, Jacopo Mariotti, Stefania Bramanti, Elisa Zaghi, Michela Calvi, Lorenzo Comba, Martina Fascì, Luisa Giaccone, Giovanni Camussi, Eileen M. Boyle, Luca Castagna, Andrea Evangelista, Domenico Mavilio & Benedetto Bruno. (2022) Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide. Frontiers in Immunology 12.
Crossref
Crossref
Simone E. JaenischCatherine A. AbbottMark D. GorrellPeter BamptonRoss N. ButlerRoger Yazbeck. (2022) Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 13:1, pages e00452.
Crossref
Crossref
Tianli Zhang, Xiang Tong, Shijie Zhang, Dongguang Wang, Lian Wang, Qian Wang & Hong Fan. (2021) The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence. Frontiers in Pharmacology 12.
Crossref
Crossref
Marie Villumsen, Astrid Blicher Schelde, Espen Jimenez-Solem, Tine Jess & Kristine Højgaard Allin. (2021) GLP-1 based therapies and disease course of inflammatory bowel disease. eClinicalMedicine 37, pages 100979.
Crossref
Crossref
Francisco Jorge Melo, Pedro Pinto-Lopes, Maria Manuela Estevinho & Fernando Magro. (2021) The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases 27:7, pages 1153-1165.
Crossref
Crossref
Marvin Szklarski, Helma Freitag, Sebastian Lorenz, Sonya C. Becker, Franziska Sotzny, Sandra Bauer, Jelka Hartwig, Harald Heidecke, Kirsten Wittke, Claudia Kedor, Leif G. Hanitsch, Patricia Grabowski, Nuno Sepúlveda & Carmen Scheibenbogen. (2021) Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Immunology 12.
Crossref
Crossref
Pedro Pinto-LopesFrancisco MeloJoana AfonsoRui Pinto-LopesCátia RochaDaniel MeloGuilherme MacedoCláudia Camila DiasFátima CarneiroFernando Magro. (2021) Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 12:3, pages e00320.
Crossref
Crossref
Meng-meng Ning, Wen-ji Yang, Wen-bo Guan, Yi-pei Gu, Ying Feng & Ying Leng. (2020) Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. Acta Pharmacologica Sinica 41:11, pages 1446-1456.
Crossref
Crossref
Pedro Pinto-Lopes, Joana Afonso, Rui Pinto-Lopes, Cátia Rocha, Paula Lago, Raquel Gonçalves, Helena Tavares De Sousa, Guilherme Macedo, Cláudia Camila Dias & Fernando Magro. (2020) Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 26:11, pages 1707-1719.
Crossref
Crossref
Yi-Chuan Chen, Tien-Hsing Chen, Chi-Chin Sun, Jau-Yuan Chen, Shy-Shin Chang, Ling Yeung & Yi-Wen Tsai. (2020) Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study. Acta Diabetologica 57:10, pages 1181-1192.
Crossref
Crossref
Honghui Wang, Xueping Gu, Huiyuan Li, Lingmei Yin, Wei Tao, Jingxing Yu, Qiyuan Zhou, Hongli Mu, Yu Shen, Jin Yao, Lin Liu, Hui Bi, Renchi Yang & Zeping Zhou. (2020) Levels of Soluble CD30 and CD26 and Their Clinical Significance in Patients with Primary Immune Thrombocytopenia. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Jong‐Mi Seong, Jeong Yee & Hye Sun Gwak. (2019) Dipeptidyl peptidase‐4 inhibitors lower the risk of autoimmune disease in patients with type 2 diabetes mellitus: A nationwide population‐based cohort study. British Journal of Clinical Pharmacology 85:8, pages 1719-1727.
Crossref
Crossref
Njanja Enz, Gwendolyn Vliegen, Ingrid De Meester & Wolfgang Jungraithmayr. (2019) CD26/DPP4 - a potential biomarker and target for cancer therapy. Pharmacology & Therapeutics 198, pages 135-159.
Crossref
Crossref
Liliana Valencia-Sánchez, Rafael Almendra-Pegueros, Luis Jose Diaz R-Valdez, David Esmer-Sánchez, Úrsula Medina & Antonio Gordillo-Moscoso. (2019) DPP-4 as a Possible Biomarker of Inflammation Before Abdominal Surgery for Chronic Pathology: Our Experience with Elective Cholecystectomy. Medicina 55:5, pages 148.
Crossref
Crossref
Marta Olivares, Valentina Schüppel, Ahmed M. Hassan, Martin Beaumont, Audrey M. Neyrinck, Laure B. Bindels, Alfonso Benítez-Páez, Yolanda Sanz, Dirk Haller, Peter Holzer & Nathalie M. Delzenne. (2018) The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health. Frontiers in Microbiology 9.
Crossref
Crossref
Suncica Buljevic, Dijana Detel, Ester P. Pugel & Jadranka Varljen. (2018) The effect of CD26‐deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease. Journal of Cellular Biochemistry 119:8, pages 6743-6755.
Crossref
Crossref
Khalaf Kridin, Kyle Amber, Mogher Khamaisi, Doron Comaneshter, Erez Batat & Arnon D. Cohen. (2018) Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunologic Research 66:3, pages 425-430.
Crossref
Crossref
Sucheera Chotikatum, Hassan Y. Naim & Nahed El-Najjar. (2018) Inflammation induced ER stress affects absorptive intestinal epithelial cells function and integrity. International Immunopharmacology 55, pages 336-344.
Crossref
Crossref
Roger Yazbeck, Simone E. Jaenisch & Catherine A. Abbott. (2017) Potential disease biomarkers: dipeptidyl peptidase 4 and fibroblast activation protein. Protoplasma 255:1, pages 375-386.
Crossref
Crossref
Hasan Saad Aldewachi, Nicola Woodroofe, Simon Turega & Philip H.E. Gardiner. (2017) Optimization of gold nanoparticle-based real-time colorimetric assay of dipeptidyl peptidase IV activity. Talanta 169, pages 13-19.
Crossref
Crossref
Yuejia Song, Min Zhou, Yang Cao, Jiping Qi, Jingshu Geng & Xiaomin Liu. (2017) Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine. Oncology Letters 13:4, pages 2684-2690.
Crossref
Crossref
Daniéla Oliveira MagroPaulo Gustavo KotzeCarlos Augusto Real MartinezMichel Gardere CamargoDioze GuadagniniAntonio Ramos CalixtoAna Carolina Junqueira VasquesMaria de Lourdes Setsuko AyrizonoBruno GelonezeJosé Carlos ParejaMario José SaadClaudio Saddy Rodrigues Coy. (2017) Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease. Intestinal Research 15:3, pages 352.
Crossref
Crossref
Milica Grujic, Ivana Z. Matic, Marija Djordjic Crnogorac, Ana Damjanovic Velickovic, Branka Kolundzija, Oscar J. Cordero, Zorica Juranic, Slavica Prodanovic, Maja Zlatanovic, Dragan Babic & Nemanja Damjanov. (2017) Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis. Clinical Chemistry and Laboratory Medicine (CCLM) 55:1, pages 73-81.
Crossref
Crossref
Dijana Detel, Suncica Buljevic, Lara Baticic Pucar, Natalia Kucic, Ester Pernjak Pugel & Jadranka Varljen. (2016) Influence of CD26/dipeptidyl peptidase IV deficiency on immunophenotypic changes during colitis development and resolution. Journal of Physiology and Biochemistry 72:3, pages 405-419.
Crossref
Crossref
C Klemann, L Wagner, M Stephan & S von Hörsten. (2016) Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. Clinical and Experimental Immunology 185:1, pages 1-21.
Crossref
Crossref
Lucie Sromova, Petr Busek, Liliana Sedova & Aleksi Sedo. (2015) Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine & Daniel H Solomon. (2015) Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Annals of the Rheumatic Diseases 74:11, pages 1968-1975.
Crossref
Crossref
Yannick Waumans, Lesley Baerts, Kaat Kehoe, Anne-Marie Lambeir & Ingrid De Meester. (2015) The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis. Frontiers in Immunology 6.
Crossref
Crossref
Takanori ShinjoYusuke NakatsuMisaki IwashitaTomomi SanoHideyuki SakodaHisamitsu IshiharaAkifumi Kushiyama, Midori Fujishiro, Toshiaki FukushimaYoshihiro TsuchiyaHideaki KamataFusanori NishimuraTomoichiro Asano. (2015) DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation. American Journal of Physiology-Endocrinology and Metabolism 309:3, pages E214-E223.
Crossref
Crossref
Kaori Fujiwara, Takuya Inoue, Naoki Yorifuji, Munetaka Iguchi, Taisuke Sakanaka, Ken Narabayashi, Kazuki Kakimoto, Sadaharu Nouda, Toshihiko Okada, Kumi Ishida, Yosuke Abe, Daisuke Masuda, Toshihisa Takeuchi, Shinya Fukunishi, Eiji Umegaki, Yasutada Akiba, Jonathan D. Kaunitz & Kazuhide Higuchi. (2015) Combined treatment with dipeptidyl peptidase 4 (DPP4) inhibitor sitagliptin and elemental diets reduced indomethacin-induced intestinal injury in rats via the increase of mucosal glucagon-like peptide-2 concentration. Journal of Clinical Biochemistry and Nutrition 56:2, pages 155-162.
Crossref
Crossref
Anna-Maria Globig, Nadine Hennecke, Bianca Martin, Maximilian Seidl, Günther Ruf, Peter Hasselblatt, Robert Thimme & Bertram Bengsch. (2014) Comprehensive Intestinal T Helper Cell Profiling Reveals Specific Accumulation of IFN-γ+IL-17+Coproducing CD4+ T Cells in Active Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:12, pages 2321-2329.
Crossref
Crossref
Lin Yang, Jiao Yuan & Zhiguang Zhou. (2014) Emerging Roles of Dipeptidyl Peptidase 4 Inhibitors: Anti-Inflammatory and Immunomodulatory Effect and Its Application in Diabetes Mellitus. Canadian Journal of Diabetes 38:6, pages 473-479.
Crossref
Crossref
Lyudmila Viktorovna Nedosugova, Nina Alexandrovna Petunina & Karina Oganesovna Galstyan. (2014) Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia. Diabetes mellitus 17:4, pages 81-86.
Crossref
Crossref
Lucienne Juillerat-Jeanneret. (2013) Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?. Journal of Medicinal Chemistry 57:6, pages 2197-2212.
Crossref
Crossref
Na-Hyung Kim, Taeyang Yu & Dae Ho Lee. (2014) The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Yunjuan Zhao, Lin Yang & Zhiguang Zhou. (2013) Dipeptidyl peptidase‐4 inhibitors: Multitarget drugs, not only antidiabetes drugs (D ipeptidyl peptidase ‐4抑制剂：多靶点药物，不仅仅是降糖药). Journal of Diabetes 6:1, pages 21-29.
Crossref
Crossref
Hasan Ulusoy, Ayhan Kamanli, Necip Ilhan, Omer Kuru, Sule Arslan, Gokhan Alkan & Salih Ozgocmen. (2011) Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis. Rheumatology International 32:12, pages 3857-3862.
Crossref
Crossref
G.W. Moran, C. O'Neill, P. Padfield & J.T. McLaughlin. (2012) Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. Regulatory Peptides 177:1-3, pages 40-45.
Crossref
Crossref
Dijana Detel, Ester Pernjak Pugel, Lara Baticic Pucar, Suncica Buljevic & Jadranka Varljen. (2012) Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV. Experimental Physiology 97:4, pages 486-496.
Crossref
Crossref
Lara Pučar, Dijana Detel & Jadranka Varljen. (2012) Dipeptidyl Peptidase IV in Inflammatory Bowel Diseases (DPP IV/CD26). Archives of Industrial Hygiene and Toxicology 63:1, pages 75-100.
Crossref
Crossref
Elijah M. Songok, Ma Luo, Ben Liang, Paul Mclaren, Nadine Kaefer, Winnie Apidi, Genevieve Boucher, Joshua Kimani, Charles Wachihi, Rafick Sekaly, Keith Fowke, Blake T. Ball & Francis A. Plummer. (2012) Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State. PLoS ONE 7:1, pages e30048.
Crossref
Crossref
Lara Baticic, Dijana Detel, Natalia Kucic, Suncica Buljevic, Ester Pernjak Pugel & Jadranka Varljen. (2011) Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS‐induced model of colitis in mice. Journal of Cellular Biochemistry 112:11, pages 3322-3333.
Crossref
Crossref
Fatma Elif Yıldırım, Ayşen Karaduman, Asli Pinar & Yasemin Aksoy. (2011) CD26/dipeptidyl‐peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy. International Journal of Dermatology 50:8, pages 948-955.
Crossref
Crossref
Lucienne Juillerat-Jeanneret, Marie-Claude Robert & Marcel A. Juillerat. (2010) Peptides from Lactobacillus Hydrolysates of Bovine Milk Caseins Inhibit Prolyl-peptidases of Human Colon Cells. Journal of Agricultural and Food Chemistry 59:1, pages 370-377.
Crossref
Crossref
Kei Ohnuma, Osamu Hosono, Nam H. Dang & Chikao Morimoto. 2011.
51
84
.
Oscar J. Cordero, Francisco J. Salgado & Montserrat Nogueira. (2009) On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunology, Immunotherapy 58:11, pages 1723-1747.
Crossref
Crossref
Osamu MatsunoEishi MiyazakiShinichi NurekiTakuya UenoMasaru AndoToshihide Kumamoto. (2017) Soluble CD26 is inversely Associated with Disease Severity in Patients with Chronic Eosinophilic Pneumonia. Biomarker Insights 1, pages 117727190600100.
Crossref
Crossref
Nathalie Busso, Nicolai Wagtmann, Christian Herling, Veronique Chobaz-Péclat, Angelika Bischof-Delaloye, Alexander So & Eric Grouzmann. (2005) Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis. The American Journal of Pathology 166:2, pages 433-442.
Crossref
Crossref
U. S. Sehmsdorf, A. C. Zenclussen, P. Arck, K. Hertwig, R. A. Joachim, B. Klapp & M. O. Hildebrandt. (2004)
Human Miscarriage is Associated with Increased Number of CD26
+
Decidual Lymphocytes
. Scandinavian Journal of Immunology 59:4, pages 400-407.
Crossref
Crossref
Chiho Makidono, Motowo Mizuno, Junichirou Nasu, Sakiko Hiraoka, Hiroyuki Okada, Kazuhide Yamamoto, Teizo Fujita & Yasushi Shiratori. (2004) Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (cd55) in patients with active ulcerative colitis. Journal of Laboratory and Clinical Medicine 143:3, pages 152-158.
Crossref
Crossref
Matthias Rose, Otto B. Walter, Herbert Fliege, Martin Hildebrandt, Hubert Mönnikes & Burghard F. Klapp. 2004. Dipeptidyl Aminopeptidases in Health and Disease. Dipeptidyl Aminopeptidases in Health and Disease
321
331
.
Emil Boonacker & Cornelis J.F. Van Noorden. (2003) The multifunctional or moonlighting protein CD26/DPPIV. European Journal of Cell Biology 82:2, pages 53-73.
Crossref
Crossref
Matthias Rose, Martin Hildebrandt, Herbert Fliege, Simone Seibold, Hubert Mönnikes & Burghard F. Klapp. (2002) T-Cell Immune Parameters and Depression in Patients With Crohn's Disease. Journal of Clinical Gastroenterology 34:1, pages 40-48.
Crossref
Crossref